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Abstract: The development of green experimental processes for the synthesis of nanoparticles is a need in the
ﬁeld of nanotechnology. The synthesis of silver nanoparticles was achieved using Bacillus cereus supernatant and
1 mM silver nitrate. 100 mM glucose was found to quicken the rate of reaction of silver nanoparticles synthesis.
UV-visible spectrophotometric analysis was carried out to assess the synthesis of silver nanoparticles. The
synthesized silver nanoparticles were further characterized by using Nanoparticle Tracking Analyzer (NTA),
Transmission Electron Microscope and Energy Dispersive X-ray spectra. These silver nanoparticles showed
enhanced quorum quenching activity against Staphylococcus aureus bioﬁlm and prevention of bioﬁlm formation
which can be seen under inverted microscope (40 X). The synergistic eﬀect of silver nanoparticles along with
antibiotics in bioﬁlm quenching was found to be eﬀective. In the near future, silver nanoparticles could be used
in the treatment of infections caused by highly antibiotic resistant bioﬁlm.
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1 Introduction
The ﬁeld of nanotechnology is one of the most active
areas of research in modern material science. Nanopar-
ticles are being considered to be the fundamental build-
ing blocks of nanotechnology. Nanotechnology is in-
terdisciplinary which includes physics, chemistry, biol-
ogy, material science and medicine. Instead of using
toxic chemicals for the reduction and stabilisation of
metallic nanoparticles, the use of various biological en-
tities has received considerable attention in the ﬁeld
of nanobiotechnology [1]. Biological methods are re-
garded as safe, cost-eﬀective, sustainable and environ-
ment friendly processes for the synthesis of nanopar-
ticles [2]. Silver nanoparticles have been successfully
synthesized using various bacteria [3-5], fungi [6, 7] and
plants [8, 9].
The term bioﬁlm has been introduced to designate
the thin layered condensations of microbes (e.g. bacte-
ria, fungi, protozoa) that may occur on various surface
structures in nature. Free-ﬂoating bacteria existing in
an aqueous environment, so-called planktonic microor-
ganisms are a prerequisite for bioﬁlm formation. Such
ﬁlms may thus become established on any organic or
inorganic surface substrate where planktonic microor-
ganisms prevail in a water-based solution. In dental
contexts, a well-known and extensively studied bioﬁlm
structure is established during the attachment of bacte-
ria to teeth to form dental plaque. Here, bacteria free
in saliva (planktonic organisms) serve as the primary
source for the organization of this speciﬁc bioﬁlm [10].
The excretion of adhesive substances viz. polysaccha-
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rides and proteins is crucial for the initial attachment
of organisms as well as for holding the bioﬁlm bacteria
together. The structure per se will then provide protec-
tion and may allow a better resistance to adverse exter-
nal inﬂuences for the organisms incorporated as com-
pared with the planktonic state [11]. Phenotypically
the organisms may also take on a diﬀerent character.
In addition, a growing body of knowledge suggests that
organisms in bioﬁlms assume a stronger pathogenic po-
tential than those in a planktonic state. From these
aspects, the formation of bioﬁlm carries particular clin-
ical signiﬁcance because not only host defense mech-
anisms, but also therapeutic eﬀorts including chemi-
cal and mechanical anti-microbial treatment measures,
have a most diﬃcult task to deal with organisms that
are gathered in a bioﬁlm [12].
In present study, silver nanoparticles are synthesized
using B. cereus supernatant. The study deals with the
eﬀect of biologically synthesized silver nanoparticles on
S. aureus bioﬁlm quenching and prevention of S. au-
reus bioﬁlm formation. Diseases such as endocarditis,
osteomyelitis and medical-device related infections are
caused by S. aureus bioﬁlms and are not readily treat-
able with antibiotics. In fact, bioﬁlms are resistant to
antibiotic levels 10- to 1,000-fold higher than plank-
tonic, or free-ﬂoating, bacteria [13]. Thus, researchers
are focusing on silver nanoparticles for the treatment of
infections caused by bioﬁlms.
2 Materials and methods
2.1 Collection of B. cereus Supernatant
Bacillus cereus (ATCC 8640) was obtained from De-
partment of Botany, Government Institute of Science,
Aurangabad (MS), India. Bacillus cereus was grown on
sterile Luria Bertani (LB-Casein enzymatic hydrolysate
10 gm/l, Yeast extract 5 gm/l, Sodium chloride 10
gm/l, Agar 25 gm/l, pH 7.5±0.2) agar plate (at 37℃).
The single isolated colony was inoculated in sterile LB
broth and incubated at 37℃ at 200 rpm in rotary
shaker for 24 hours. After incubation, culture was cen-
trifuged at 4500 rpm for 10 minutes, the supernatant
was collected.
2.2 Synthesis of silver nanoparticles using cul-
ture supernatant of B.cereus
Bacterial supernatant was mixed with 1 mM silver
nitrate in 1:1 proportion. The pH of solution was ad-
justed to 9.0-9.5 [14] and then resultant solutions were
kept in rotary shaker (200 rpm) at 37℃ till the change
in the colour of the solution was observed.
2.3 Synthesis of silver nanoparticles using cul-
ture supernatant of B. cereus along with 100
mM glucose
Bacterial supernatant :1mM silver nitrate :100 mM
glucose were mixed in 1:1:1 proportion. The pH of so-
lution was adjusted to 9.0-9.5. The resultant solution
was kept in rotary shaker (200 rpm) at 37℃.
2.4 UV-visible spectrophotometer analysis
After observing colour change, the sample was sub-
jected to mild sonication for 10 minutes. The bioreduc-
tion of silver ions in aqueous solution was monitored by
UV-Vis spectra of the solution between 300 nm–600 nm
using Thermo- Biomate 3 UV-visible spectrophotome-
ter. Distilled water was taken to adjust the baseline.
2.5 Nanoparticle Tracking Analyzer (NTA)
Measurements
NTA analysis was carried out by using Nanosight-
LM20 instrument. 0.3 ml samples were introduced to
the viewing unit using a disposable syringe and en-
hanced by a near perfect black background; particles
appear individually as point-scatterers moving under
Brownian motion.
2.6 Transmission Electron Microscopy (TEM)
and Energy Dispersive X-ray Spectra
(EDX) analysis
TEM analysis of the sample was done using
PHILIPS- CM 200 instrument operated at an accel-
erating voltage of 200 kV with resolution of 0.23 nm.
A drop of solution was placed on carbon coated copper
grid and later exposed to infrared light (45 minutes) for
solvent evaporation. The EDX analysis was carried out
using JEOL JSM 7600F.
2.7 In vitro synthesis of Staphylococcus aureus
bioﬁlm
The bioﬁlm related studies have been performed
with the modiﬁcation of protocol suggested by Kaplan-
Ragunath-Ramasubbu-Fine [15] and King-Tatum [16].
Tryptone soy broth (TSB- Pancreatic digest of casein 17
gm/l, Papaic digest of Soyabean meal 3 gm/l, Sodium
chloride 5 gm/l, Dipotassium hydrogen phosphate 2.5
gm/l, Dextrose 2.5 gm/l, pH 7.3± 2) with 1% of glucose
was inoculated with single isolated colony of S.aureus
(NCIM 5022) and was incubated at 37℃ for 24 hrs.
After incubation culture was diluted with fresh TSB-
1% glucose in 5:100 proportion, then 200 μl of diluted
culture was added in 96 well micro titer plate and in-
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cubated at 37℃ for 48 hrs [15, 16].
2.8 Addition of quenching agent in Staphylococ-
cus aureus bioﬁlm
First column of wells was served as positive control in
which 25 μl of 20 % sodium dodecyl sulphate was added,
second column of wells was served as negative con-
trol (untreated bioﬁlm). In the third column of wells,
50 μl of concentrated silver nanoparticles were added.
About 50 μl of diﬀerent antibiotics solution, Gentam-
icin (10 μg/ml) and Chloramphenicol (20μg/ml) were
added in fourth and ﬁfth column of wells respectively.
To check synergistic eﬀect of silver nanoparticles along
with antibiotics 25 μl of silver nanoparticles along with
25 μl of above antibiotics were added in sixth and sev-
enth column of wells separately. In eighth column of
wells 50 μl of 1mM AgNO3 was added. The plate was
incubated at 37℃ for overnight.
After incubation, plate was washed with 200 μl of
phosphate buﬀer saline (pH-7.2) to remove ﬂoating bac-
teria. Micro titer plate was stained with 100 μl of 0.1
% crystal violet for 2 minutes then washed with dis-
tilled water. Then add 200 μl of 33 % acetic acid and
incubate for 5 minutes. Then Plate was properly dried
in laminar air ﬂow cabinet. Plate was analysed under
inverted microscope (40 X) to record the results. The
whole experiment has been performed in triplicate to
ensure the reproducibility of the results.
2.9 Eﬀect of silver nanoparticles in prevention
of Staphylococcus aureus bioﬁlm formation
Overnight grown Staphylococcus aureus culture was
diluted 1:100 in fresh Tryptone soya broth and allowed
to grow for 1 hour. About 200μl of diluted culture was
added to micro titer plate. One column of wells was
served as positive control (25μl of 20% sodium dodecyl
sulphate); second column of wells was served as nega-
tive control (untreated culture). In the third column
of wells, 50 μl of concentrated silver nanoparticles were
added. In fourth column of well 50μl of 1mM AgNO3
was added. Plate was incubated at 37℃ for 3 days [17].
Washing and staining was done by method mentioned
above.
3 Results and discussion
3.1 Synthesis of silver nanoparticles using B.
cereus culture supernatant
Colour change was observed upon mixing the B.
cereus culture supernatant with aqueous solution of 1
mM silver nitrate in 1:1 (pH 9.0-9.5), which was incu-
bated at 37℃ for 24 hours (Fig. 1). Flask containing
culture supernatant of B. cereus along with 100mM
glucose and silver nitrate showed intense colour change
than the method of synthesizing silver nanoparticles us-
ing culture supernatant alone. Intense colour change
suggested that the synthesis of silver nanoparticles may
be more in the case of this method.
(a) (b) (c)
Fig. 1 (a) Initial reaction mixture containing B. cereus
supernatant and 1 mM silver nitrate in 1:1 ratio; (b) Color
change of reaction mixture containing B. cereus supernatant
and 1 mM silver nitrate in 1:1 ratio; (c) Color change of reac-
tion mixture containing B. cereus supernatant, 1 mM silver
nitrate and 100 mM glucose in 1:1:1 ratio.
3.2 UV-visible spectrophotometer analysis
The synthesis of silver nanoparticles by reduction of
aqueous metal ions during exposure of B. cereus su-
pernatant can be easily monitored by using UV-visible
spectrophotometer. Figure 2 illustrates the absorbance
spectra of reaction mixture containing aqueous solu-
tion of 1mM silver nitrate and B. cereus culture super-
natant after incubation. Reaction mixture showed an
absorbance peak at around 425nm, which is character-
istic of silver nanoparticles, due to its surface plasmon
resonance absorption band [18]. In case of the synthesis
mediated by B. cereus supernatant in the presence of
100mM glucose, the absorbance peak was obtained at
around 425nm.
B.cereus supernatant

















































Fig. 2 UV-visible spectrophotometer analysis of silver
nanoparticles synthesized using B. cereus supernatant and
B. cereus supernatant in presence of 100 mM glucose.
3.3 NTA measurements
NTA measurements revealed that the mean size of
synthesized silver nanoparticles was found to be 39 nm
with concentration of 7.8×1010 particles/ml in case of
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Fig. 3 Frequency size distribution graph of silver nanopar-
ticles synthesized using B. cereus supernatant. X axis: par-











Fig. 4 TEM micrograph of silver nanoparticles synthesized
using (a) B. cereus supernatant; (b) and (c) B. cereus su-
pernatant and 100 mM glucose.
Bacterial supernatant mediated synthesis. The mean
size of silver nanoparticles synthesized using bacterial
supernatant in presence of glucose was found to be
32 nm with concentration of 10.4×1010 particles/ml
(Fig. 3).
3.4 TEM and EDX analysis
TEM analysis revealed that the silver nanoparticles
are prominently spherical (Fig. 4). The silver nanopar-
ticles were found to be well dispersed from each other.
The EDX analysis revealed that the silver is present in
the solution (Fig. 5). The silver content in the particles
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Fig. 5 EDX spectra of silver nanoparticles solution.
3.5 Quorum quenching Eﬀect of silver
nanoparticles on Staphylococcus aureus
Bioﬁlm
Silver nanoparticles showed quenching of bioﬁlm
which can be compared with negative control antibi-
otics failed to show bioﬁlm quenching alone which can
be compared with positive control. But synergistic ef-
fect of silver nanoparticles and antibiotic showed the
bioﬁlm quenching. 1mM silver nitrate also did not
show any quenching of bioﬁlm. (Fig. 6(a-h))
3.6 Eﬀect of silver nanoparticles in Prevention
of Staphylococcus aureus bioﬁlm Formation
Silver nanoparticles showed prevention of bioﬁlm for-
mation which can be compared with negative con-
trol. Where as positive control showed distinct bioﬁlm
formed which indicates that silver nanoparticles prevent
formation of bacterial bioﬁlm. (Fig. 6(i)) It is known
that the excretion of adhesive substances viz. polysac-
charides and proteins is crucial for the initial attach-
ment of organisms as well as for holding the bioﬁlm
bacteria together [11]. The silver nanoparticles might
be involved in neutralizing these adhesive substances,
thus preventing bioﬁlm formation.
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Fig. 6 Eﬀect of silver nanoparticles in bioﬁlm quenching and prevention of S. aureus bioﬁlm formation under inverted
microscope (40X) (a): Negative control (intact bioﬁlm); (b): Positive control (Bioﬁlm Quenched using 20% SDS); (c):
Silver nanoparticles; (d): Gentamicin (10 μg/ml); (e): Chloramphenicol (20 μg/ml); (f): Silver nanoparticles + Gentamicin
(10 μg/ml); (g): Silver nanoparticles+ Chloramphenicol (20 μg/ml); (h): 1mM silver nitrate; (i): Silver nanoparticles in
prevention of bioﬁlm formation.
4 Conclusion
In the present study, silver nanoparticles have been
synthesized using B. cereus supernatant alone and B.
cereus supernatant in the presence of glucose. The in-
creased synthesis of silver nanoparticles was achieved in
case of B. cereus supernatant in the presence of glucose.
The exact role played by glucose in enhancing the rate
of synthetic reaction of silver nanoparticles will be the
ﬁeld of research interest.
In the present study, eﬀect of silver nanoparticles in
bioﬁlm quenching and prevention of bioﬁlm formation
has been demonstrated. From the results it can be
concluded that silver nanoparticles can be involved in
bioﬁlm quenching or prevention of bioﬁlm formation.
However, antibiotics failed to show any quenching of
bacterial bioﬁlm. Synergistic eﬀect of silver nanoparti-
cles along with antibiotics in bioﬁlm quenching has also
been demonstrated in this study. The exact mechanism
of action of silver nanoparticles in bioﬁlm related stud-
ies is yet to be demonstrated. In the near future, silver
nanoparticles may play a major role in the treatment of
infections caused by highly antibiotic resistant bioﬁlm.
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